Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL)Francesco Gelsomino, Andrea Ardizzoni, Angelo Delmonte et al.|British Journal of Cancer|2020Cited by 25
Phase II study of NAB-paclitaxel in sensitive and refractory relapsed SCLC (NABSTER TRIAL)Francesco Gelsomino, Andrea Ardizzoni, Marcello Tiseo et al.|Annals of Oncology|2018Cited by 2
Correction to: Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL)Francesco Gelsomino, Andrea Ardizzoni, Marcello Tiseo et al.|British Journal of Cancer|2021Cited by 0